These results demonstrate that the drug‐induced decrease in cell viability observed in H1915 lung cancer cells, homozygous for the R351W mutation, is due to inhibition of somatically mutated ABL1, which represents a druggable genetic dependency in this cell line. This evidence concerns the gene ABL1 and lung carcinoma.